Cargando…

One-pot multi-component synthesis of novel chromeno[4,3-b]pyrrol-3-yl derivatives as alpha-glucosidase inhibitors

A green and efficient one-pot multi-component protocol was developed for the synthesis of some novel dihydrochromeno[4,3-b]pyrrol-3-yl derivatives through the reaction of arylglyoxals, malono derivatives, and different 4-amino coumarins in ethanol at reflux condition. In this method, all products we...

Descripción completa

Detalles Bibliográficos
Autores principales: Karami, Malihe, Hasaninejad, Alireza, Mahdavi, Hossein, Iraji, Aida, Mojtabavi, Somayeh, Faramarzi, Mohammad Ali, Mahdavi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544188/
https://www.ncbi.nlm.nih.gov/pubmed/34697701
http://dx.doi.org/10.1007/s11030-021-10337-w
_version_ 1784589761587970048
author Karami, Malihe
Hasaninejad, Alireza
Mahdavi, Hossein
Iraji, Aida
Mojtabavi, Somayeh
Faramarzi, Mohammad Ali
Mahdavi, Mohammad
author_facet Karami, Malihe
Hasaninejad, Alireza
Mahdavi, Hossein
Iraji, Aida
Mojtabavi, Somayeh
Faramarzi, Mohammad Ali
Mahdavi, Mohammad
author_sort Karami, Malihe
collection PubMed
description A green and efficient one-pot multi-component protocol was developed for the synthesis of some novel dihydrochromeno[4,3-b]pyrrol-3-yl derivatives through the reaction of arylglyoxals, malono derivatives, and different 4-amino coumarins in ethanol at reflux condition. In this method, all products were obtained in good to excellent yield. Next, all synthesized derivatives were evaluated for their α-glucosidase inhibitory activity. Most of the compounds displayed potent inhibitory activities with IC(50) values in the range of 48.65 ± 0.01–733.83 ± 0.10 μM compared to the standard inhibitor acarbose (IC(50) = 750.90 ± 0.14 μM). The kinetic study of compound 5e as the most potent derivative (IC(50) = 48.65 ± 0.01 μM) showed a competitive mechanism with a K(i) value of 42.6 µM. Moreover, docking studies revealed that dihydrochromeno[4,3-b]pyrrol-3-yl effectively interacted with important residues in the active site of α-glucosidase. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11030-021-10337-w.
format Online
Article
Text
id pubmed-8544188
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-85441882021-10-26 One-pot multi-component synthesis of novel chromeno[4,3-b]pyrrol-3-yl derivatives as alpha-glucosidase inhibitors Karami, Malihe Hasaninejad, Alireza Mahdavi, Hossein Iraji, Aida Mojtabavi, Somayeh Faramarzi, Mohammad Ali Mahdavi, Mohammad Mol Divers Original Article A green and efficient one-pot multi-component protocol was developed for the synthesis of some novel dihydrochromeno[4,3-b]pyrrol-3-yl derivatives through the reaction of arylglyoxals, malono derivatives, and different 4-amino coumarins in ethanol at reflux condition. In this method, all products were obtained in good to excellent yield. Next, all synthesized derivatives were evaluated for their α-glucosidase inhibitory activity. Most of the compounds displayed potent inhibitory activities with IC(50) values in the range of 48.65 ± 0.01–733.83 ± 0.10 μM compared to the standard inhibitor acarbose (IC(50) = 750.90 ± 0.14 μM). The kinetic study of compound 5e as the most potent derivative (IC(50) = 48.65 ± 0.01 μM) showed a competitive mechanism with a K(i) value of 42.6 µM. Moreover, docking studies revealed that dihydrochromeno[4,3-b]pyrrol-3-yl effectively interacted with important residues in the active site of α-glucosidase. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11030-021-10337-w. Springer International Publishing 2021-10-25 2022 /pmc/articles/PMC8544188/ /pubmed/34697701 http://dx.doi.org/10.1007/s11030-021-10337-w Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Karami, Malihe
Hasaninejad, Alireza
Mahdavi, Hossein
Iraji, Aida
Mojtabavi, Somayeh
Faramarzi, Mohammad Ali
Mahdavi, Mohammad
One-pot multi-component synthesis of novel chromeno[4,3-b]pyrrol-3-yl derivatives as alpha-glucosidase inhibitors
title One-pot multi-component synthesis of novel chromeno[4,3-b]pyrrol-3-yl derivatives as alpha-glucosidase inhibitors
title_full One-pot multi-component synthesis of novel chromeno[4,3-b]pyrrol-3-yl derivatives as alpha-glucosidase inhibitors
title_fullStr One-pot multi-component synthesis of novel chromeno[4,3-b]pyrrol-3-yl derivatives as alpha-glucosidase inhibitors
title_full_unstemmed One-pot multi-component synthesis of novel chromeno[4,3-b]pyrrol-3-yl derivatives as alpha-glucosidase inhibitors
title_short One-pot multi-component synthesis of novel chromeno[4,3-b]pyrrol-3-yl derivatives as alpha-glucosidase inhibitors
title_sort one-pot multi-component synthesis of novel chromeno[4,3-b]pyrrol-3-yl derivatives as alpha-glucosidase inhibitors
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544188/
https://www.ncbi.nlm.nih.gov/pubmed/34697701
http://dx.doi.org/10.1007/s11030-021-10337-w
work_keys_str_mv AT karamimalihe onepotmulticomponentsynthesisofnovelchromeno43bpyrrol3ylderivativesasalphaglucosidaseinhibitors
AT hasaninejadalireza onepotmulticomponentsynthesisofnovelchromeno43bpyrrol3ylderivativesasalphaglucosidaseinhibitors
AT mahdavihossein onepotmulticomponentsynthesisofnovelchromeno43bpyrrol3ylderivativesasalphaglucosidaseinhibitors
AT irajiaida onepotmulticomponentsynthesisofnovelchromeno43bpyrrol3ylderivativesasalphaglucosidaseinhibitors
AT mojtabavisomayeh onepotmulticomponentsynthesisofnovelchromeno43bpyrrol3ylderivativesasalphaglucosidaseinhibitors
AT faramarzimohammadali onepotmulticomponentsynthesisofnovelchromeno43bpyrrol3ylderivativesasalphaglucosidaseinhibitors
AT mahdavimohammad onepotmulticomponentsynthesisofnovelchromeno43bpyrrol3ylderivativesasalphaglucosidaseinhibitors